An evaluation of Ufonia’s conversational agent Dora for cataract surgery follow-up

Not Applicable

Completed

• Conditions: Clinical follow-up of postoperative symptoms in patients who have undergone routine cataract surgery; Surgery

• Registration Number: ISRCTN16038063
• Lead Sponsor: Imperial College London

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39050586/ (added 29/07/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-11
• Study Completion: 2022-03-24
• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 225

Inclusion Criteria

1. Willing and able to provide informed consent
2. Aged 18 years or older
3. On the waiting list for routine cataract surgery. Cataract surgery as part of a combined procedure with other ocular surgery will not be included
4. No history or presence of significant ocular comorbidities that would be expected to alter the risks of cataract surgery or normal post-operative follow-up schedule. Note that significant ocular comorbidities do not include stable, chronic, or inactive ocular conditions such as amblyopia, drop-controlled stable glaucoma or ocular hypertension, previous squint surgery, inactive macular pathology, previous refractive surgery, or previous vitreoretinal surgery with stable retina

Exclusion Criteria

1. Individuals with any condition that could preclude the ability to comply with the study or follow-up procedures
2. Presence of ocular or systemic uncontrolled disease (unless deemed not clinically significant by the Investigator and Sponsor)
3. Involved in current research related to this technology or been involved in related research to this technology prior to recruitment
4. Cognitive difficulties, hearing impairment or non-English speakers
5. History of current or severe, unstable or uncontrolled systemic disease (unless deemed not clinically significant by the Investigator and Sponsor)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Agreement is measured by inter-rater reliability (the degree of agreement between DORA and the clinician on their assessments of the individual symptoms and the management plan) and whether or not the clinician had to interrupt the call to ask clarifying questions. Measured at 0 days.